chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received  vaccine and did not got and sit down, was watching her husband get his and about 5 minutes after giving the shot, she fainted and fell backwards, was alert in about 10 seconds after hitting the ground, ems was called, vitals monitored until they arrived, no anaphylaxis
We had a float medical assistant fill in a shift today.  He has worked at our clinic a few times but has never been trained by me or any of my staff on administering the Pfizer vaccine.  He did state that he had gone through the training from the CDC.  We had a patient come in for her second dose of Pfizer and the medical assistant got our a MDV of the Pfizer (6 dose).  I told him to set it on the counter and needed to be out for 15 minutes.  After the 15 min. the medical assistant drew up the entire contents of the vial and went and administered to the patient in the Right Arm.   I came out from a phone call and noticed an empty bottle of Pfizer on the counter.  I rushed to the room and asked if he had mixed the vaccine and he stated yes.  When he came out of the room with the patient I asked him if he had mixed with the diluent.  He stated no, that he thought it was like moderna and just drew up the contents of the vial and gave it to the patient.   I talked to the patient and explained the situation.  She was very upset but she did NOT have any side effects or complaints after waiting in the office for 40 minutes.  I had the Physician also talk to her about what to look for or be concerned about.  I contacted the local health department and talked to a representative.  She advised me to report the event to VAERS and also the State Vaccine Managment team.   I have talked to the patient a few hours later and she is still without any symptoms.
On 4/23/2023, I developed a scratchy throat. On 4/24/2023, I woke up with a scratchy throat and felt like I was catching a cold, but my cabin mate on the cruise ship I was travelling on felt even sicker than I did, so she called for medical assistance. She tested positive for COVID-19. I was also tested that day, and my results were negative, but I was feeling sicker instead of better as time progressed. On 4/26/2023, I was tested again, and I got a positive result. I felt like I had a bad head cold for the rest of the week. I had runny nose, cough, sneezing, and sore throat. The ship's doctor gave me a bottle of OTC cough syrup, which did not help much with my symptoms. On 4/29/2023, I came home from the cruise. I continued coughing, and it was a productive cough. I continued taking the cough syrup from the cruise ship, but I also started taking OTC ALKA-SELTZER plus cold and flu, which helped control the fever. On 5/3/2023, I called my PCP, who prescribed me an albuterol inhaler. After that, I gradually got better. I took a home antigen test on 5/7/2023 and finally got a negative result for the first time. At the present time, I feel fatigued and am sleeping a lot. However, I'm no longer coughing a lot.
Pt had feelings of needles on and off to both palms of hands and bottom of feet.  She states that its getting worse. Pt is having trouble sleeping.
Patient was given the Pfizer COVID-19 vaccine 8 days after the extended expiration date.  The patient did well during the waiting period after the vaccine.  Poison Control was called .  We planned to re-vaccinate per guidance from the Poison Control Center.   At this time the patient has declined re-vaccination.  He stated that he felt the vaccine would be sufficient .
Approximately 22 hours after receiving g the covid vaccine, I had sudden onset vomiting, diarrhea, chills, and felt like I was going to faint. Episode lasted approximately 10 minutes (thus far).
Pt reported that he was vaccinated around 2:45 pm and at 6:45 pm the same day began to feel nauseous and light headed. He states he was so weak he had trouble getting into bed. He also experienced feeling cold and sweaty. He states he took his temperature and did not have a fever. He states he felt a little better around 8:30 pm and ate crackers and soup. He states he didn't sleep well and was still nauseous and felt like he had heartburn around 5 am. He states he was able to eat at 7 am the next morning (3/13) and took a shower around noon. Pt states he took his blood pressure on the morning of 3/13 and that it was low. He says he took his blood pressure daily until the 22nd, and it took about a week for it to return to normal for him. Pt reports that he saw his primary care provider on 3/18/21 and his EKG was normal but his BMP was elevated. PCP referred him to cardiologist.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site warmth in a 58-year-old male patient who received SHINGRIX (batch number 9XC39, expiry date 30th January 2020). Concurrent medical conditions included hyperthyroidism. Concomitant products included atorvastatin. On 16th January 2018, the patient received the 1st dose of SHINGRIX .5 ml. In January 2018, less than a week after receiving SHINGRIX, the patient experienced injection site warmth, sleepiness and generalized joint pain. In January 2018, the outcome of the injection site warmth and sleepiness were recovering/resolving and the outcome of the generalized joint pain was recovered/resolved. The reporter considered the injection site warmth and generalized joint pain to be related to SHINGRIX. The reporter considered the sleepiness to be possibly related to SHINGRIX. Additional details were provided as follows: The reporter was notified on the day of reporting by the patient about the side effects he experienced and if the second dose of the vaccine should be given. The patient did not give any timeframes as to when the side effects started after receiving the vaccine. When the patient came into the pharmacy on the day of reporting, the reporter could feel that the skin at the injection site was still warm to the touch. The reporter felt the skin through the patient's shirt. The body aches were experienced in the joints in the entire body of the patient. The reporter was told by the patient that he had sleepiness and could not stay awake. The reporter said that sleepiness was atypical for this patient.
The patient is a 61-year-old male with history of DM type II and hypertension presented to emergency department complaining of generalized weakness and difficulty walking.  Patient stated that he got his second COVID-19 vaccination 2 days ago after which his symptoms started to progressively get worse.  At our facility patient is noted to be febrile, dehydrated, and tachycardic requiring oxygen.  His COVID-19 test is negative.  He is compliant with his home medications.  He tolerated his first COVID-19 vaccine without any complications.  He did have COVID-19 infection in March, 2021 and recovered without complications at home with over counter medications.    61-year-old who states that he has become weaker and unable to ambulate for the past 2 weeks.  Denies any chest pain.  Denies any cough sputum production.  He has not had any fever rigors or chills.. Received the Covid vaccine second dose 2 days ago but states that he these problems for approximately 2 years or so.  He had a coronary angiogram at USC at that time.  He states that he was told to take Coreg spironolactone and bumetanide.  He is a never smoker.  States that he stopped alcohol many years ago.    Assessment/Plan  1. Cardiogenic shock   Echo shows EF of 10% 2. Cardiomyopathy  3. Anasarca   Discharge summary: Hospital Course       61 years old male with past medical history of cardiomyopathy and chronic systolic congestive heart failure, history of diabetes and hypertension who presented to the emergency room complaining generalized weakness and difficulty ambulating, patient states that he received his second dose of Covid 19 vaccine 2 days prior to his symptoms, patient started to get weak and his symptoms got progressively worse, on arrival to the emergency room patient was found to have a fever of 38.2 was tachycardic and tachypneic as well requiring oxygen, his COVID-19 test in the emergency room was negative per patient when he received his first Covid vaccine was without any complication at that time patient was given 2 L of fluids in the emergency room and our team was consulted to admit the patient, patient also was noted to be hypoglycemic in the emergency room and his hyperglycemia worsen and became hypotensive at that time I evaluated the patient he was responsive and able to open his eyes and follow simple command, patient was started on Levophed drip and ICU was called for admission given patient instability, he had an echo that showed left ventricular ejection fraction of about 10% and patient was admitted to the ICU, patient continued on antibiotics for possible pneumonia and UTI and had paracentesis done after the procedure patient had a CODE BLUE and he was intubated with return of pulse and blood pressure although he had another code at that time ICU discussed with the family given his comorbidity and poor prognosis given patient had 2 cardiac arrest and family requested for the patient to be do not escalate and patient was pronounced dead at 21:47
swelling, reddness, rash 6cm x 3cm @ site; dx cellulitis; rx w/Augmentin
The pt developed cellulitis post vaccination. The pt was seen by a physician and treated with antibiotics
Patient received a vaccine past the beyond used by date; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event) outcome was unknown.      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the beyond used by date).    Concomitant medication was not reported.  Treatment medication was not reported.  This case included information of patient 110th out of 190 reported patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:Master case
Patient felt lightheaded, dizzy, and nauseated within 5 minutes of receiving the vaccine. He was sweating excessively and hyperventilating . He was unable to stand up, so he lay on the floor in front of the pharmacy until paramedics arrived. He was transported out of the store by the paramedics.
High fever >102, nausea, vomiting,  all over body pain, severe headache
No adverse event; Product storage error; This spontaneous report was received from a medical assistant referring to a 5-year-old female patient.  The patient's pertinent medical history, current conditions, drugs reactions or allergies and concomitant medication were not provided.  On 25-APR-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis, lot number U025790, has been verified to be a valid lot number with expiration date on 19-AUG-2023, administered subcutaneously (strength, dose, scheme frequency and anatomical location were not provided).  The vaccines underwent temperature excursion of -14 degrees Celsius up to -10 degrees Celsius during a time frame of 3 hours; -10 degrees Celsius up to 8 degrees Celsius during a time frame of 1 hour and 30 minutes. No adverse event was reported.  There was no previous temperature excursion. It was stated that temperature was recorded by digital data logger.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2205USA008051: US-009507513-2205USA008004: US-009507513-2204USA009330:
03/03/22 presents to Birth Center Triage for "contractions" "40w4d". "No pertinent past medical history"
Pt denies fever, chills. Shortly after injection site red, arm swollen. Next day still with swelling redness to affected arm. Two days after injection couldn't raise arm, eyes swollen, cheeks inflammed. Three days some SOB. Seen 10/14/02-face swollen, swelling pain left arm. Tx: Madrol dose pak and Benadryl. Still resolving.
This spontaneous report was received from a pharmacist refers to a 62 year old female patient. No pertinent medical history was reported. On 31-MAR-2015, the patient was vaccinated with ZOSTAVAX Vial (lot # K020185 and expiration date 27-JAN-2016), dose 0.65 ml, subcutaneous. Concomitant therapies included SYNTHROID. On 02-APR-2015, the patient experienced contusion, pruritus, redness at the injection site, the redness also extended  down to her elbow. Patient sought medical attention. On an unspecified date, the patient was seen by her unspecified physician for evaluation and was provided with an unspecified treatment. Symptoms were still present, however, they were improving. The pharmacist denied that any rash, lesions, spots, papules or blisters were present and reported that the red area was not raised at all. Action taken was not applicable. The outcome of events was recovering/resolving. Causality was not assessed by the reporter. Additional information has been requested.
Patient began to feel itchy around scalp and neck.  Patient never continued to throat or tongue issues but was given 25mg of Benadryl for prevention.  She returned to work within 30 minutes with no continuation of symptoms.
Immediately following vaccine tingling in face and mouth and headache.  Following days severe headache, severe fatigue, slight temperature, tightness in chest all the way around the rib cage and difficulty taking a deep breathe developed a few days after getting vaccine and lasted 24 hours
Vaccine was administered beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administered beyond use date after the thaw process) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administered beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administered beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient's age was reported as 51 years 1 month.  No concomitant medications were provided by the reporter.  It was reported that vaccines were administered beyond use date after the thaw process. There was no patient that had any adverse reactions and no reports of any reactions after the administration of the vaccines.  No treatment medications were provided by the reporter.
Admitted to hospital with Guillain Barre syndrome. Onset of symptoms 11/29/2005 tingling extremities. 12/01 difficulty walking, 12/03 admitted to hospital due to low back pain and difficulty walking. 12/05 numbness in lower extremities, limited range of motion, weakness in all extremities. Transferred to different hospital on 12/05/2005. Discharge summary states pain of skin, atelecticsis, respiratiory insufficency. msv Per 60 day follow up report- Continues to receive IVIG every other week. Condition gradually improving. Still has impaired mobility. Foley cath remains anchored PEG tube removed 2-28-06. Was a swing bed patient at out facility 1/10/06 to 2/7/06. Currently continuing recovery at home. 02/08/2007 per patient repat- states has rediual effects including diminished sensation in feet from the ankles down.  Still has some balance problems.  One numb finger.  He has returned to work.
In addition to discomfort in the upper left arm which was expected and has resolved, the proximal interphalangeal joint on my right ring finger became extremely discolored. It is a dark purplish red. This started just around the PIP joint but appears to be moving down towards the main portion of the hand. I have osteoarthritis in this joint, but I have never experienced this discoloration before. There is not an excessive amount of swelling but very obvious discoloration. I am not able to take anti-inflammatory meds so I am at a loss to know bow to proceed.
Left arm became sore and red.  Increased in size over the next 3 days.  Seen on 05/31/2012 4:30PM.  Left arm swollen and red and warm to touch the size of a soft ball. tx with Keflex 500 mg BID for & days.  Patient to return on 06/04/2012.
Menstrual Cycle was occurring at regular intervals and normal duration prior to COVID 19 vaccination. 8 months post vaccination, only one menstrual cycle has occurred approximately during September, it was heavier than normal.  In addition, to lack of a menstrual cycle, I am experiencing  "hot flashes".
pt c/o dizziness immed p/vax; instructed to rest head on desk resulting in syncopal episode lasting approx 2 mins; pt was placed on floor p90, BP 150/90  responded in approx 1 min;
Dose # 1 and Dose # 2 of COVID vaccine were administered 12 days apart.   Dose # 2 given on 01/11/2021. Pfizer Lot #: EL3246, Given IM in Left Arm  No adverse reaction from patient
Within 12-14 hrs of vaccination, pt felt hot, felt feverish, area of vaccine irritated, itchy, red, warm to touch. No treatment. Pt vaccinated with yellow fever in right arm.
After an unspecified dose of Lymerix, the pt became extremely ill with among other symptoms severe joint and back pain. Reportedly at a physician's recommendation, the pt underwent coccygectomy in 9/99. This surgery reported was ineffective and directly resulted in an osteomyelitis infection. As of 2/1/01, the outcome of the events is unknown.
3 hrs after receiving vaccines c/o feeling warm, (not temp checked). Mom noted pt. acting "delirious" talking but not making sense - lasted approx. 10 minutes. He felt tired into early evening. (Mother just reported this all to us today 11/12/13).
Pregnant and received the Moderna Covid-19 Vaccine today; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant and received the Moderna Covid-19 Vaccine today) in a 32-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (Socially). Concurrent medical conditions included Penicillin allergy and Hashimoto's thyroiditis (Has not been given any treatment) since 2016. Concomitant products included ONDANSETRON (ZOFRAN [ONDANSETRON]) from 15-Jun-2020 to 23-Jan-2021 for Nausea in pregnancy, PRE NATAL FORMULA from 07-Mar-2020 to an unknown date for Pregnancy.    On 23-Dec-2020 at 1:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 30-Apr-2020 and the estimated date of delivery was 04-Feb-2021. On 23-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant and received the Moderna Covid-19 Vaccine today). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-third week of the pregnancy. The vaginal delivery occurred, which was reported as Full-term.There was perinatal complications or fetal/infant abnormalities. No abnormalities were noted at 1 month post-partum. On 23-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant and received the Moderna Covid-19 Vaccine today) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-May-2020, Pregnancy test: positive (Positive) Positive. In July 2020, Ultrasound scan: normal (normal) normal. In September 2020, Ultrasound scan: normal (normal) normal. In November 2020, Glucose tolerance test: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.  The patient had one live full term birth.  The estimated date of conception was reported as 30-May-2020. The patient had no maternal history of subfertility and had established prenatal care. There was no complications or acute illness reported during tis pregnancy.   This case was linked to MOD-2020-001339 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: The patient information, pregnancy information and concomitant product dosage information were updated.; Sender's Comments: This is a case of product exposure during pregnancy with no associated adverse events for this female patient. Patient will continue to be contacted for further monitoring of adverse events during the pregnancy.
Itching, burning, and redness around the injection site for 2 days. Today (3rd day) it?s red but no burning or itch.
Developed induration and erythema 7 days after Tdap (Adacel). Started as 4 vesicles and then induration of arm. And received IPV and typhoid Vi polysaccharide in same arm.
The patient received an improperly stored dose of ROTATEQ; No adverse symptoms reported; This spontaneous report was received from a medical assistant referring to a patient of unknown and gender. No information regarding the patients' pertinent medical history, concomitant therapies or previous drug reaction or allergies was provided.  On 02-MAR-2020, the patient was vaccinated with a improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) vial administered orally (lot # 1660112 and expiration date of 18-OCT-2020; strength, dose, formulation and anatomical location) as prophylaxis. The vaccine was stored at a temperature above 47 degrees Fahrenheit (F) for 15 minutes. Previous temperature excursion: 47 F for 21 minutes (product storage error). Digital data logger was involved. No adverse symptoms were reported (no adverse event).
The area of the injection was slightly warm and swelled mildly with an itching sensation for about an hour.
Broke out in hives; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of URTICARIA (Broke out in hives) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced URTICARIA (Broke out in hives). At the time of the report, URTICARIA (Broke out in hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment: Patient broke out in hives last weekend and has been on an oral dose of prednisone.   Reporter did not allow further contact
Breakthrough case admission after 2 vaccines Pfizer 8/30/21 Lot# Ew0164;  Pfizer 9/20/21 Lot# EW0164
C/o arm being swollen, red, achy, warm to touch. Tx: ice, Tylenol prn. Zyrtec 10mg 1 daily x 5 days.